Recent

% | $
Quotes you view appear here for quick access.

OXiGENE, Inc. Message Board

  • vvvvvvrebel89130 vvvvvvrebel89130 Mar 27, 2014 8:42 AM Flag

    thanks to emerging analyst & geoff on o/s

    looks like it really varies, but i have a much clearer picture of what o/s has been reported and basically what we hope to beat

    thanks guys
    this is what these message boards are for; sharing information to help us make intelligent investing decisions, not the bashing/pumping bs

    i'm still not clear on when the oxgn trial started; the pr on enrollment being completed is dated april 2013; if we use that as a marker we're at 11mths and counting, so i would think we would need o/s to extend to summer for it to be statistically significant;
    big thinks the trial started 2 years ago; i'm just not sure; no offense big

    "In the trial, patupilone and liposomal doxorubicin produce the same PFS (3.7 months median) and a comparable OS (13.2 vs 12.7 months)."

    OS of 4.7 and 17 months, respectively. In addition, 40% of patients remained progression-free at 6 months.

    median PFS of 4.4 months [95% confidence interval (CI) 3.1–5.5 months], and median OS of 10.7 months. A

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
OXGN
0.7031-0.0269(-3.68%)Jun 17 4:00 PMEDT